In an industry first, CREAL will integrate its light field
display technology into Zeiss' vision care devices, greatly
simplifying vision tests, and thereby enhancing the patient and
eye-care practitioner user experience.
LAUSANNE, Switzerland and AALEN, Germany, Sept. 10,
2024 /PRNewswire/ -- CREAL today announces a license
agreement with ZEISS with the aim to create a digitized vision care
platform that hopes to revolutionize the current vision diagnostic
and treatment procedures. By leveraging CREAL's light field display
technology, ZEISS will bring to market devices that allow for the
digital examination of eye conditions as well as virtual simulation
of classic ophthalmic lenses, contact lenses, and the like.
Ultimately, the partnership should help bring century-old vision
test procedures into the 21st century, finally enabling
fast, cost-effective and above all user-friendly diagnostic
procedures.
Many of today's refraction tests are time-consuming, costly and
can even seem intimidating. Manual and lens-based, they rely on
outdated technology. As well as all eye care practitioners, these
constraints affect a great part of the population. For instance,
more than two-thirds of the population in the US wear glasses or
contacts[1], while myopia is constantly growing and is
expected to affect 50% of the global population by
2050[2]. The need for intuitive, accurate, effective,
and cost-efficient vision tests and diagnosis is therefore only to
become even more crucial.
Through the integration of CREAL's light field display into
vision test devices, ZEISS expects to introduce a groundbreaking
solution allowing for precise digital diagnosis of eye defects. By
replicating real-world light to provide digital imagery with
genuine depth, CREAL's true 3D display will enable the digital
replication of any physical or theoretical lens, allow test
procedures to be tailored to any age group/customer segment, as
well as enable the projection of automated content, limiting the
need for clinical resources overall.
"As the pioneer of scientific optics, ZEISS' mission has always
been to challenge the limits of human imagination," says Antia
Alonso Ph.D., Vice President of Zeiss Vision Technology Solutions.
"We see our collaboration with CREAL and the consequent development
and rollout of our digitized vision care platform as a way to
revolutionize the prescription eyewear customer buying experience,
elements of which still rely on antiquated technology, developed
over a century ago."
Looking ahead, the synergy between ZEISS' expertise in vision
care and eyewear, and CREAL's cutting-edge advancements in display
technology could help accelerate the development of vision-health
and vision enhancement enterprise in all its forms, both real
and virtual.
[1] "The Consumer inSights Q1 2002 report", The
Vision Council's
[2] Padmaja Sankaridurg, et al, "Impact of Myopia," ARVO
Journals, Investigative Ophthalmology & Visual Science, Vol.62,
2, April 2021
About CREAL
CREAL is a display technology startup based in Switzerland, with a technical team drawn from
cutting-edge projects at Intel, Magic Leap, EPFL and CERN. CREAL
has developed a patented light field micro-display technology
stack, uniquely projecting images with true-to-life depth. While
serving vision care applications, CREAL naturally expands its
mission toward Augmented Reality hardware. With the same business
model and partners among the market leaders in the vision
care/eyewear industry, CREAL ultimately enables a much-needed
natural and healthy visual experience of digital content. To know
more, please visit www.creal.com.
About ZEISS Vision Care
ZEISS Vision Care is one of the world's leading manufacturers of
eyeglass lenses and ophthalmic instruments. The unit is allocated
to the Consumer Markets segment and develops and produces offerings
for the entire eyeglass value chain that are distributed globally
under the ZEISS brand. Further information at
www.zeiss.com
Photo: https://mma.prnewswire.com/media/2498433/CREAL.jpg
Logo:
https://mma.prnewswire.com/media/2498434/CREAL_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zeiss-to-license-creals-technology-to-create-a-digital-vision-care-platform-302241881.html
SOURCE CREAL